Abstract We examined the relations of gender differences in electrocardiographic (ECG) voltages and QRS duration to differences in cardiac dimensions and body size between men and women and gender ...

A higher incidence of LVH associated with persistent nondipping pattern reasonably represents cardiac response to a sustained increase of LV systolic stress throughout the 24-h period. Thus ...

Native T1 was used to assess the within-subject changes in seropositive individuals. Logistic regression was performed to assess the association between SARS-CoV-2 antibody status and the incidence of ...

Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for Myosin-Binding Protein C3-associated hypertrophic cardiomyopathy ...

The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference,  March 29-31, bringing an array of ...

gmail.com Background Differentiating physiological left ventricular hypertrophy (LVH) in athletes from pathological hypertrophic cardiomyopathy (HCM) can be challenging. This study assesses the ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

1 Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands 2 Department of Cardiology, Leiden University Medical Center, The Netherlands Correspondence to Dr Jurrien M ten Berg, ...

and when left ventricular (LV) hypertrophy exists, they do not regress LV mass as well as diuretics. In addition, there were BP differences between the two treatment limbs favoring the ...

Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...